Promising new drug combination for melanoma patients resistant to treatment
Melanoma is the most common form of skin cancer, but for patients with advanced melanoma who no longer respond to standard immunotherapy, treatment options are painfully limited. Vanderbilt researchers led by Professor Emerita ...
Oct 27, 2025
0
0
